Colleen Keyes
Pulmonary Disease · Boston, MANPI 1124167093
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Intuitive Surgical at 34.2% of the total. Reporting peaked in 2023 at $4,682 and has fallen 67.6% since, to $1,515 in 2025.
Across 41 payments — averaging $247.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Cook Incorporated$3K
- Pulmonx Corporation$3K
- Boston Scientific$314
- Pinnacle Biologics, Inc$165
- Penumbra, Inc.$129
- plus $236 from 3 others
Across 11 payments — averaging $4062.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intuitive Surgical Operations, Inc.$32K
- BD$12K
What the payments were for
- Speaking & faculty fees$4,49844%
- Travel & lodging$3,11831%
- Food & beverage$2,52925%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 21 | $3,468 |
| Cook Incorporated | 1 | $2,998 |
| Pulmonx Corporation | 7 | $2,836 |
| Boston Scientific | 5 | $314 |
| Pinnacle Biologics, Inc | 2 | $165 |
| Penumbra, Inc. | 1 | $129 |
| AstraZeneca | 1 | $125 |
| Cook Medical LLC | 2 | $66 |
| Olympus America Inc. | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Blue Rhino$2,998
- Da Vinci Surgical System$2,964
- ZEPHYR ENDOBRONCHIAL VALVE$2,702
- PULMONX CHARTIS TABLET CONSOLE$2,702
- ZEPHYR DELIVERY CATHETER$2,702
- CHARTIS CATHETER$2,702
- Indigo System$129
- BREZTRI$125
- Photofrin$125
How this compares
$10,145 in reported general payments places this provider in the 85th percentile of 482 pulmonary disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 16 | $264 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Boston
- Erik FolchBoston$543K
- Bartolome CelliBoston$536K
- Adnan MajidBoston$351K
- Nicholas HillBoston$293K
- Harrison FarberBoston$190K
- Tufik AssadBoston$132K
- Anthony FaugnoBoston$132K
- Hyun KimBoston$117K
- George WashkoBoston$101K
- Aaron WaxmanBoston$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.